BIOCERES CROP SOLUTIONS CORP. Proceeds From Borrowings Classified As Financing Activities
BIOCERES CROP SOLUTIONS CORP. (BIOX) reported Proceeds From Borrowings Classified As Financing Activities of $17.01 million for the 6-month period ending 2025-12-31, per its 6-K filed 2026-03-13.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities · last filed 2026-03-13
- BIOCERES CROP SOLUTIONS CORP. proceeds from borrowings classified as financing activities for the quarter ending 2025-12-31 was $5.17M, a 86.61% decline year-over-year.
- BIOCERES CROP SOLUTIONS CORP. proceeds from borrowings classified as financing activities for the quarter ending 2025-09-30 was $11.85M, a 70.30% decline year-over-year.
- BIOCERES CROP SOLUTIONS CORP. proceeds from borrowings classified as financing activities for the quarter ending 2025-06-30 was $126.33M.
- BIOCERES CROP SOLUTIONS CORP. proceeds from borrowings classified as financing activities for the quarter ending 2025-03-31 was $61.59M, a 11.94% decline year-over-year.
| Period end | Proceeds From Borrowings Classified As Financing Activities 3 month | Proceeds From Borrowings Classified As Financing Activities 6 month | Proceeds From Borrowings Classified As Financing Activities 6 month as first filed | Proceeds From Borrowings Classified As Financing Activities 9 month | Proceeds From Borrowings Classified As Financing Activities 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $5.17M derived: 6-K 6 month − 6-K 3 month · filed 2026-03-13 | $17.01M 6-K · filed 2026-03-13 | $143.34M derived: sum of 3 quarters · filed 2026-03-13 | $204.93M derived: sum of 4 quarters · filed 2026-03-13 | |
| 2025-09-30 | $11.85M 6-K · filed 2025-11-26 | $138.18M derived: sum of 2 quarters · filed 2025-11-26 | $199.76M derived: sum of 3 quarters · filed 2025-11-26 | $238.35M derived: sum of 4 quarters · filed 2026-03-13 | |
| 2025-06-30 | $126.33M derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | $187.92M derived: sum of 2 quarters · filed 2025-11-10 | $226.50M derived: sum of 3 quarters · filed 2026-03-13 | $266.39M 20-F · filed 2025-11-10 | |
| 2025-03-31 | $61.59M derived: 6-K 9 month − 6-K 6 month · filed 2025-06-20 | $100.17M derived: sum of 2 quarters · filed 2026-03-13 | $140.06M 6-K · filed 2025-06-20 | $136.13M derived: sum of 4 quarters · filed 2026-03-13 | |
| 2024-12-31 | $38.58M derived: 6-K 6 month − 6-K 3 month · filed 2026-03-13 | $78.47M 6-K · filed 2026-03-13 | $84.10M 6-K · filed 2025-02-28 | $74.54M derived: sum of 3 quarters · filed 2026-03-13 | $144.48M derived: sum of 4 quarters · filed 2026-03-13 |
| 2024-09-30 | $39.89M 6-K · filed 2025-11-26 | $35.96M derived: sum of 2 quarters · filed 2025-11-26 | $105.90M derived: sum of 3 quarters · filed 2025-11-26 | $148.87M derived: sum of 4 quarters · filed 2025-11-26 | |
| 2024-06-30 | -$3.93M derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | $66.01M derived: sum of 2 quarters · filed 2025-11-10 | $108.98M derived: sum of 3 quarters · filed 2025-11-10 | $135.82M 20-F · filed 2025-11-10 | |
| 2024-03-31 | $69.94M derived: 6-K 9 month − 6-K 6 month · filed 2025-06-20 | $112.91M derived: sum of 2 quarters · filed 2025-06-20 | $139.75M 6-K · filed 2025-06-20 | $38.74M derived: sum of 4 quarters · filed 2025-11-10 | |
| 2023-12-31 | $42.97M derived: 6-K 6 month − 6-K 3 month · filed 2025-02-28 | $69.81M 6-K · filed 2025-02-28 | -$31.20M derived: sum of 3 quarters · filed 2025-11-10 | $12.75M derived: sum of 4 quarters · filed 2025-11-10 | |
| 2023-09-30 | $26.84M 6-K · filed 2024-11-27 | -$74.18M derived: sum of 2 quarters · filed 2025-11-10 | -$30.23M derived: sum of 3 quarters · filed 2025-11-10 | $13.33M derived: sum of 4 quarters · filed 2025-11-10 | |
| 2023-06-30 | -$101.01M derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | -$57.06M derived: sum of 2 quarters · filed 2025-11-10 | -$13.51M derived: sum of 3 quarters · filed 2025-11-10 | $79.82M 20-F · filed 2025-11-10 | |
| 2023-03-31 | $43.95M derived: 6-K 9 month − 6-K 6 month · filed 2024-05-29 | $87.50M derived: sum of 2 quarters · filed 2024-05-29 | $180.83M 6-K · filed 2024-05-29 | $212.18M derived: sum of 4 quarters · filed 2024-10-30 | |
| 2022-12-31 | $43.55M derived: 6-K 6 month − 6-K 3 month · filed 2024-02-28 | $136.88M 6-K · filed 2024-02-28 | $168.23M derived: sum of 3 quarters · filed 2024-10-30 | $197.39M derived: sum of 4 quarters · filed 2024-10-30 | |
| 2022-09-30 | $93.33M 6-K · filed 2023-11-29 | $124.68M derived: sum of 2 quarters · filed 2024-10-30 | $153.84M derived: sum of 3 quarters · filed 2024-10-30 | ||
| 2022-06-30 | $31.35M derived: 20-F 12 month − 6-K 9 month · filed 2024-10-30 | $60.51M derived: sum of 2 quarters · filed 2024-10-30 | $140.43M 20-F · filed 2024-10-30 | ||
| 2022-03-31 | $29.16M derived: 6-K 9 month − 6-K 6 month · filed 2023-05-24 | $109.08M 6-K · filed 2023-05-24 | |||
| 2021-12-31 | $79.92M 6-K · filed 2023-02-28 | ||||
| 2021-06-30 | $143.50M 20-F · filed 2023-11-14 | ||||
| 2020-12-31 | $69.54M 6-K · filed 2022-02-25 | ||||
| 2020-06-30 | $135.35M 20-F · filed 2022-10-28 | ||||
| 2019-12-31 | $55.54M 6-K · filed 2021-02-26 | ||||
| 2019-06-30 | $88.69M 20-F · filed 2021-10-29 | ||||
| 2018-12-31 | $37.77M 6-K/A · filed 2020-03-17 | ||||
| 2018-06-30 | $27.75M 20-F · filed 2020-10-21 | ||||
| 2017-06-30 | $60.34M 20-F · filed 2019-10-24 | ||||
| 2016-12-31 | $10.55M 20-F · filed 2019-10-24 |